Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of...

by Luber Birgit, Deplazes Joëlle, Keller Gisela, Walch Axel, Rauser Sandra, Eichmann Martin, Langer Rupert, Höfler Heinz, Hegewisch-Becker Susanna, Folprecht Gunnar, Wöll Ewald, Decker Thomas, Endlicher Esther, Lorenzen Sylvie, Fend Falko, Peschel Christian, Lordick Florian
Published 2011-12-01